169 related articles for article (PubMed ID: 38610011)
1. "In our community, we normalize pain": discussions around menstruation and uterine fibroids with Black women and Latinas.
Orellana M; DSouza KN; Yap JQ; Sriganeshan A; Jones ME; Johnson C; Allyse M; Venable S; Stewart EA; Enders F; Balls-Berry JE
BMC Womens Health; 2024 Apr; 24(1):233. PubMed ID: 38610011
[TBL] [Abstract][Full Text] [Related]
2. Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids.
Orellana M; Riggan KA; DSouza K; Stewart EA; Venable S; Balls-Berry JE; Allyse MA
J Racial Ethn Health Disparities; 2022 Aug; 9(4):1184-1191. PubMed ID: 34013445
[TBL] [Abstract][Full Text] [Related]
3. The Environment, Leiomyomas, Latinas, and Adiposity Study: rationale and design.
Manuel EC; Plowden TC; Valbuena FM; Bryce RL; Barick AA; Ramakrishnan A; Carnethon MR; Neff LM; Baird DD; Marsh EE
Am J Obstet Gynecol; 2022 Mar; 226(3):392.e1-392.e12. PubMed ID: 33974903
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
5. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
[TBL] [Abstract][Full Text] [Related]
6. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
7. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
8. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M
J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950
[TBL] [Abstract][Full Text] [Related]
9. An Altered Perception of Normal: Understanding Causes for Treatment Delay in Women with Symptomatic Uterine Fibroids.
Ghant MS; Sengoba KS; Vogelzang R; Lawson AK; Marsh EE
J Womens Health (Larchmt); 2016 Aug; 25(8):846-52. PubMed ID: 27195902
[TBL] [Abstract][Full Text] [Related]
10. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT.
Daniels J; Middleton LJ; Cheed V; McKinnon W; Rana D; Sirkeci F; Manyonda I; Belli AM; Lumsden MA; Moss J; Wu O; McPherson K
Health Technol Assess; 2022 Apr; 26(22):1-74. PubMed ID: 35435818
[TBL] [Abstract][Full Text] [Related]
11. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
12. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
[TBL] [Abstract][Full Text] [Related]
13. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
[TBL] [Abstract][Full Text] [Related]
14. One year symptom severity and health-related quality of life changes among Black African patients undergoing uterine fibroid embolisation.
Mariara C; Obura T; Hacking N; Stones W
BMC Res Notes; 2017 Jul; 10(1):240. PubMed ID: 28676073
[TBL] [Abstract][Full Text] [Related]
15. Black Women's Psychosocial Experiences with Seeking Surgical Treatment for Uterine Fibroids: Implications for Clinical Practice.
VanNoy BN; Bowleg L; Marfori C; Moawad G; Zota AR
Womens Health Issues; 2021; 31(3):263-270. PubMed ID: 33610438
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women.
Zimmermann A; Bernuit D; Gerlinger C; Schaefers M; Geppert K
BMC Womens Health; 2012 Mar; 12():6. PubMed ID: 22448610
[TBL] [Abstract][Full Text] [Related]
17. Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women's emotional and psychosocial health.
Ghant MS; Sengoba KS; Recht H; Cameron KA; Lawson AK; Marsh EE
J Psychosom Res; 2015 May; 78(5):499-503. PubMed ID: 25725565
[TBL] [Abstract][Full Text] [Related]
18. A single baseline ultrasound assessment of fibroid presence and size is strongly predictive of future uterine procedure: 8-year follow-up of randomly sampled premenopausal women aged 35-49 years.
Baird DD; Saldana TM; Shore DL; Hill MC; Schectman JM
Hum Reprod; 2015 Dec; 30(12):2936-44. PubMed ID: 26409013
[TBL] [Abstract][Full Text] [Related]
19. Patient Recommendations for Shared Decision-Making in Uterine Fibroid Treatment Decisions.
Riggan KA; Stewart EA; Balls-Berry JE; Venable S; Allyse MA
J Patient Exp; 2021; 8():23743735211049655. PubMed ID: 34692992
[TBL] [Abstract][Full Text] [Related]
20. Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.
Stewart EA; Al-Hendy A; Lukes AS; Madueke-Laveaux OS; Zhu E; Proehl S; Schulmann T; Marsh EE
Am J Obstet Gynecol; 2024 Feb; 230(2):237.e1-237.e11. PubMed ID: 37863160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]